An underground economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.
Investigational Treatment Acquiring Popularity Online
The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are encouraged to contact these profiles privately for supplier links, while also obtaining promotional offers.
Active Commerce on Social Networks
Separately, a flourishing trade exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and assertions of rapid British shipping. Vendors promote the substance there before redirecting customers to other platforms for transactions.
Understanding The Experimental Drug
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Experts Voice Concerns
However, doctors and chemists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals administering products of unknown origin.
Several experts said the demand for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.
Some content creators try to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach pharmaceutical, marketing, and consumer regulations, risking penalties, prosecution or prison.
Platform Reaction and Material Removal
Based on TikTok, the platform has taken down problematic content and banned associated keywords and search suggestions. The company said it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.
Online Marketplace Activities
Research also discovered groups with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with numerous of users, populated with photos of slimming results, positive testimonials and detailed guides for preparing or injecting at residence.
Within minutes of entering one group, a seller posted contact information, where most transactions occur. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.
Product Details and Costs
Inside these groups, posts show black plastic packages with postal service stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When asked how much time a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for the messaging service said it actively monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting materials they can’t verify. Although the science behind this drug is sound, these digital products may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to social media. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she said.
Her team has previously seen patients injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company experimental substance not yet approved … may subject users to possibly serious medical dangers”.
